---All---
  • ---All---
  • Accession
  • Catalog #

Cytokeratin-5 Antibody (C-term)Rabbit Monoclonal Antibody

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1227c 100ul 400 ul 2-3 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Cytokeratin-5 Antibody (C-term) - Product info

ApplicationWB, IHC, IF
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP13647
ReactivityHuman
Clone NamesEP1601Y
Calculated MW62378 Da
Gene ID 3852
Other Names
KRT5, Keratin, type II cytoskeletal 5, 58 kDa cytokeratin
Target/Specificity
A synthetic peptide corresponding to residues on the C-terminus of human CK-5 was used as an immunogen.
Dilution
WB~~1:10000~50000
IHC~~1:100~250
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Cytokeratin-5 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

Cytokeratin-5 Antibody (C-term) - Protein Information

Name KRT5

Cytokeratin-5 Antibody (C-term) - Application data

  • A. Western blot analysis on A431 cell lysate using anti-CK-5 RabMAb (Cat. #AJ1227c), dilution1:10,000

  • B. Immunohistochemical analysis of paraffin-embedded human transitional urinary bladder carcinoma using anti-CK5RabMAb.(Cat. #AJ1227c).

  • C. Immunofluorescent staining of A431 cells using anti-CK-5 RabMAb (Cat. #AJ1227c).

Cytokeratin-5 Antibody (C-term) - Related products

RI12963: KRT5 predesign siRNA

AT2660a: KRT5 Antibody (monoclonal) (M08)

AO1114a: Cytokeratin 5 Antibody

AO1115a: Cytokeratin (Pan) Antibody

AO1256a: Cytokeratin 5 Antibody

AO1269a: Cytokeratin(Pan) Antibody

AJ1227a: Cytokeratin-5 Antibody

AJ1227b: Cytokeratin-5 Antibody

AJ1227c: Cytokeratin-5 Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Keratins are a family of structurally related proteins that form the intermediate filament cytoskeleton in epithelial cells. The 58-kD keratin CK-5 is highly similar to other type II keratins and less similar to type I keratins and other intermediate filament proteins. The 58-kD keratin is regulated by retinoids in several tissues and is one of four keratins abundantly expressed in epidermal keratinocytes, where it may be important in maintaining structural integrity of the integument (1). Keratin 5 (CK-5) mRNA and protein are shown to be expressed in normal mammary epithelial cells in culture and are absent from tumor-derived cell lines. This makes CK-5 an important marker in the tumorigenic process, distinguishing normal from tumor cells, and decreased CK-5 expression correlates with tumorigenic progression (2). Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation of the flexures. Loss of function of CK-5 suggests a crucial role for keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage (3).

REFERENCES

1. Eckert RL, et al. DNA 7(5):337-45, 1988.
2. Trask DK, et al. Proc Natl Acad Sci 87(6)2319-23, 1990
3. Betz RC, et al. Am J Hum Genet 78(3):510-9, 2006.